NCI-H226 [H226] Cell Line: A Deep Dive into Its Role in Lung Cancer Research

by

Introduction

Lung cancer remains a leading cause of cancer-related deaths worldwide, with mesothelioma and non-small cell lung cancer (NSCLC) being particularly aggressive subtypes (National Cancer Institute). Among the available in vitro models, the NCI-H226 [H226] cell line is widely used to study lung cancer biology, molecular pathways, and therapeutic responses.

Origin and Establishment of NCI-H226 Cells

The NCI-H226 cell line was derived from a pleural effusion of a patient with squamous cell carcinoma, a subtype of NSCLC (Cellosaurus Database). Developed at the National Cancer Institute (NCI), it has since been extensively utilized in research studies to understand tumor progression, metastasis, and resistance mechanisms (PubMed).

Genetic and Molecular Characteristics

NCI-H226 cells exhibit genetic alterations commonly found in lung cancer, including:

  • TP53 Mutation: A crucial mutation affecting tumor suppression, leading to unchecked cell proliferation (NCBI).
  • EGFR Wild-Type Status: Unlike some NSCLC lines, H226 lacks EGFR mutations, making it a model for studying non-EGFR-driven lung cancer (Cancer Genome Atlas).
  • MET Amplification: This genetic alteration contributes to tumor growth and resistance to certain therapies (NIH).
  • PTEN Alterations: PTEN loss has been associated with increased aggressiveness in lung cancer (PubMed).

Cellular and Morphological Features

Microscopic analysis reveals that NCI-H226 cells are adherent with an epithelial-like morphology. They form monolayers in culture, closely mimicking squamous cell carcinoma tumors (ATCC).

Culture and Growth Conditions

For optimal growth, NCI-H226 cells require the following conditions:

  • Medium: RPMI-1640 supplemented with 10% fetal bovine serum (FBS – Heat Inactivated Qualified Imported Fetal Bovine Serum, USDA Approved)
  • Atmosphere: 37°C with 5% CO2
  • Doubling Time: Approximately 36-48 hours (DSMZ)
  • Adherent Nature: Cells require proper attachment substrates to grow efficiently.
  • Passaging Recommendations: Subculturing is recommended at 80-90% confluency to maintain optimal growth conditions.
  • Cryopreservation: Cells should be frozen in 90% FBS and 10% DMSO for long-term storage.

Applications in Lung Cancer Research

The NCI-H226 cell line plays a critical role in cancer studies, with broad applications including:

1. Tumor Progression and Metastasis

Researchers use this model to explore molecular pathways driving squamous cell carcinoma progression, particularly transcriptional factors regulating tumor invasion (PubMed).

2. Drug Screening and Resistance Mechanisms

NCI-H226 is used to evaluate chemotherapy and targeted therapy responses, particularly in cisplatin-based treatments and resistance studies (NIH).

3. Radiation Sensitivity Studies

This cell line has been employed in studies examining radiation therapy effects on squamous cell lung cancer, aiding in personalized treatment strategies (Cancer.gov).

4. Immunotherapy Research

As immunotherapy becomes a standard treatment for lung cancer, NCI-H226 helps assess the efficacy of checkpoint inhibitors like PD-1/PD-L1 blockers (NCI).

5. Gene Expression and Epigenetic Studies

Scientists use NCI-H226 to analyze epigenetic modifications such as DNA methylation and histone modifications, which play significant roles in lung cancer development (NIH Epigenetics Program).

6. Co-Culture Systems and Microenvironment Studies

Recent advancements have enabled the use of NCI-H226 in co-culture systems with fibroblasts, immune cells, and endothelial cells to mimic the tumor microenvironment (NCBI).

7. Organoid and 3D Culture Models

Researchers are developing organoid models derived from NCI-H226 to study drug responses in a more physiologically relevant setting (NIH 3D Models Program).

Challenges and Limitations

Despite its importance, the NCI-H226 cell line has certain limitations:

  • Limited Representation of Tumor Heterogeneity: Single-cell models may not fully capture patient tumor diversity (Cancer.gov).
  • Lack of Immune Components: Like most in vitro models, H226 does not include immune interactions, which are crucial in modern therapies (NIH Immuno-Oncology Studies).
  • Variable Drug Sensitivity: Different subclones of H226 may exhibit varied responses to drugs, making reproducibility a challenge (PubMed).
  • Genetic Drift Over Passages: Extended culturing may result in genetic and phenotypic drift, affecting experimental reproducibility (NCBI).

Future Directions

To enhance its translational value, researchers are integrating 3D organoid cultures, co-culture systems with stromal cells, and CRISPR gene-editing techniques to better replicate patient tumors (NCBI). Additionally, single-cell RNA sequencing is being applied to explore intra-tumoral heterogeneity in greater detail (NIH).

Conclusion

NCI-H226 is a crucial tool for lung cancer research, offering valuable insights into tumor biology, drug resistance, radiation sensitivity, and therapeutic efficacy. With advances in genomics, cell engineering, and immunotherapy, this model continues to drive precision medicine and novel treatment strategies. Researchers worldwide are leveraging its unique characteristics to improve our understanding of squamous cell carcinoma and develop more effective treatment options.

For additional resources, explore the National Cancer Institute, PubMed, and NIH Clinical Trials.

 

NCI-H226 [H226] Cell Line: A Deep Dive into Its Role in Lung Cancer Research

by

Introduction

Lung cancer remains a leading cause of cancer-related deaths worldwide, with mesothelioma and non-small cell lung cancer (NSCLC) being particularly aggressive subtypes (National Cancer Institute). Among the available in vitro models, the NCI-H226 [H226] cell line is widely used to study lung cancer biology, molecular pathways, and therapeutic responses.

Origin and Establishment of NCI-H226 Cells

The NCI-H226 cell line was derived from a pleural effusion of a patient with squamous cell carcinoma, a subtype of NSCLC (Cellosaurus Database). Developed at the National Cancer Institute (NCI), it has since been extensively utilized in research studies to understand tumor progression, metastasis, and resistance mechanisms (PubMed).

Genetic and Molecular Characteristics

NCI-H226 cells exhibit genetic alterations commonly found in lung cancer, including:

  • TP53 Mutation: A crucial mutation affecting tumor suppression, leading to unchecked cell proliferation (NCBI).
  • EGFR Wild-Type Status: Unlike some NSCLC lines, H226 lacks EGFR mutations, making it a model for studying non-EGFR-driven lung cancer (Cancer Genome Atlas).
  • MET Amplification: This genetic alteration contributes to tumor growth and resistance to certain therapies (NIH).
  • PTEN Alterations: PTEN loss has been associated with increased aggressiveness in lung cancer (PubMed).

Cellular and Morphological Features

Microscopic analysis reveals that NCI-H226 cells are adherent with an epithelial-like morphology. They form monolayers in culture, closely mimicking squamous cell carcinoma tumors (ATCC).

Culture and Growth Conditions

For optimal growth, NCI-H226 cells require the following conditions:

  • Medium: RPMI-1640 supplemented with 10% fetal bovine serum (FBS)
  • Atmosphere: 37°C with 5% CO2
  • Doubling Time: Approximately 36-48 hours (DSMZ)
  • Adherent Nature: Cells require proper attachment substrates to grow efficiently.

Applications in Lung Cancer Research

The NCI-H226 cell line plays a critical role in cancer studies, with broad applications including:

1. Tumor Progression and Metastasis

Researchers use this model to explore molecular pathways driving squamous cell carcinoma progression, particularly transcriptional factors regulating tumor invasion (PubMed).

2. Drug Screening and Resistance Mechanisms

NCI-H226 is used to evaluate chemotherapy and targeted therapy responses, particularly in cisplatin-based treatments and resistance studies (NIH).

3. Radiation Sensitivity Studies

This cell line has been employed in studies examining radiation therapy effects on squamous cell lung cancer, aiding in personalized treatment strategies (Cancer.gov).

4. Immunotherapy Research

As immunotherapy becomes a standard treatment for lung cancer, NCI-H226 helps assess the efficacy of checkpoint inhibitors like PD-1/PD-L1 blockers (NCI).

5. Gene Expression and Epigenetic Studies

Scientists use NCI-H226 to analyze epigenetic modifications such as DNA methylation and histone modifications, which play significant roles in lung cancer development (NIH Epigenetics Program).

Challenges and Limitations

Despite its importance, the NCI-H226 cell line has certain limitations:

  • Limited Representation of Tumor Heterogeneity: Single-cell models may not fully capture patient tumor diversity (Cancer.gov).
  • Lack of Immune Components: Like most in vitro models, H226 does not include immune interactions, which are crucial in modern therapies (NIH Immuno-Oncology Studies).
  • Variable Drug Sensitivity: Different subclones of H226 may exhibit varied responses to drugs, making reproducibility a challenge (PubMed).

Future Directions

To enhance its translational value, researchers are integrating 3D organoid cultures, co-culture systems with stromal cells, and CRISPR gene-editing techniques to better replicate patient tumors (NCBI). Additionally, single-cell RNA sequencing is being applied to explore intra-tumoral heterogeneity in greater detail (NIH).

Conclusion

NCI-H226 is a crucial tool for lung cancer research, offering valuable insights into tumor biology, drug resistance, radiation sensitivity, and therapeutic efficacy. With advances in genomics, cell engineering, and immunotherapy, this model continues to drive precision medicine and novel treatment strategies. Researchers worldwide are leveraging its unique characteristics to improve our understanding of squamous cell carcinoma and develop more effective treatment options.

For additional resources, explore the National Cancer Institute, PubMed, and NIH Clinical Trials.

 

Exploring Human Pancreatic Cancer Cells: A Comprehensive Study on PaTu 8988t

by

Introduction

Pancreatic cancer remains one of the most aggressive and lethal malignancies, with a five-year survival rate of less than 10% (National Cancer Institute). Among the various in vitro models used to study this disease, the PaTu 8988t cell line has emerged as a valuable tool for understanding the molecular mechanisms of pancreatic adenocarcinoma and for testing potential therapeutic agents.

Origin and Establishment of PaTu 8988t Cells

PaTu 8988t cells were derived in 1985 from a liver metastasis of a primary pancreatic adenocarcinoma in a 64-year-old female patient (Cellosaurus Database). This cell line was developed alongside its sister cell line, PaTu 8988s, which originates from the same tumor but exhibits different biological characteristics. While PaTu 8988s represents a less differentiated phenotype, PaTu 8988t retains more epithelial-like features, making it an essential model for studying pancreatic cancer differentiation and metastasis (PubMed).

Genetic and Molecular Characteristics

PaTu 8988t cells display several key genetic mutations that are hallmarks of pancreatic cancer. These include:

  • KRAS Mutation: The KRAS oncogene is frequently mutated in pancreatic cancers. PaTu 8988t cells harbor a homozygous p.Gly12Val mutation, which plays a pivotal role in uncontrolled cell growth (NCBI).
  • TP53 Mutation: A homozygous p.Arg282Trp mutation in the tumor suppressor gene TP53 is present, affecting cell cycle regulation and apoptosis (Cancer Genome Atlas).
  • SMAD4 Deletion: The loss of SMAD4, a gene involved in the TGF-β signaling pathway, contributes to increased tumor aggressiveness and poor prognosis (PubMed).

Cellular and Morphological Features

Microscopic analysis of PaTu 8988t cells reveals an adherent, epithelial-like morphology with features of differentiation. When injected into nude mice, these cells form tubular structures that resemble those found in primary pancreatic adenocarcinoma, providing researchers with an excellent in vivo model for studying tumor progression (ATCC).

Culture and Growth Conditions

For optimal growth, PaTu 8988t cells require the following culture conditions:

  • Medium: Dulbecco’s Modified Eagle Medium (DMEM)
  • Serum: 5% fetal bovine serum (FBS) + 5% horse serum
  • Supplements: 2 mM L-glutamine
  • Doubling Time: 22-30 hours (DSMZ)

These cells thrive in standard 37°C incubators with 5% CO2, making them relatively easy to maintain for laboratory research.

Applications in Cancer Research

The PaTu 8988t cell line has been widely used in pancreatic cancer studies, with applications including:

1. Tumor Biology and Metastasis Research

By comparing PaTu 8988t with its sister cell line PaTu 8988s, scientists can examine differences in metastatic potential and differentiation status (PubMed).

2. Drug Screening and Therapeutic Development

Due to its well-characterized KRAS and TP53 mutations, PaTu 8988t serves as an excellent model for testing targeted therapies such as MEK inhibitors and TP53 reactivators (NIH).

3. Genetic and Epigenetic Studies

PaTu 8988t cells allow researchers to investigate the impact of epigenetic modifications and gene expression alterations in pancreatic cancer progression (National Library of Medicine).

Challenges and Limitations

While PaTu 8988t has proven to be a valuable research tool, it is essential to acknowledge its limitations:

  • Genomic Instability: Like many cancer cell lines, PaTu 8988t undergoes genetic drift over multiple passages, which may alter experimental outcomes (Cell Line Authentication Consortium).
  • Lack of Immune System Interactions: In vitro models do not fully replicate tumor-immune system interactions, which are crucial for understanding therapeutic responses (NIH Immuno-Oncology Studies).
  • Differences from Primary Tumors: Despite its high fidelity to pancreatic adenocarcinoma, cell line models may not fully capture the heterogeneity observed in human tumors (Cancer.gov).

Future Directions

To enhance the translational impact of research using PaTu 8988t, scientists are exploring 3D culture systems, patient-derived xenografts (PDX), and organoids to better mimic pancreatic tumor microenvironments (NCBI). CRISPR-Cas9 technology is also being leveraged to create genetically modified versions of PaTu 8988t, allowing for the study of specific gene functions (NIH).

Conclusion

PaTu 8988t is an essential pancreatic cancer cell line, providing researchers with an invaluable in vitro model for studying tumor biology, drug responses, and molecular signaling pathways. With ongoing advances in genomic technologies and tumor modeling, this cell line continues to drive discoveries aimed at improving pancreatic cancer diagnosis and treatment.

For more information, explore resources from National Cancer Institute and PubMed.

 

Recombinant Mouse Sonic Hedgehog Protein (Shh), Partial (Active): Functions, Applications, and Research Insights

by

Introduction to Sonic Hedgehog Protein (Shh)

The Sonic Hedgehog (Shh) protein is a critical signaling molecule involved in embryonic development, cell differentiation, and tissue regeneration. The recombinant Mouse Sonic Hedgehog protein (Shh), Partial (Active) is widely used in biomedical research to study its role in developmental biology, neurogenesis, and cancer progression.

For more information on Sonic Hedgehog signaling, visit the National Institutes of Health (NIH) (nih.gov) and the National Center for Biotechnology Information (NCBI) (ncbi.nlm.nih.gov).

Structure and Mechanism of Action

The Sonic Hedgehog (Shh) protein belongs to the Hedgehog (Hh) signaling family, which also includes Desert Hedgehog (Dhh) and Indian Hedgehog (Ihh). The active recombinant form of the protein retains its N-terminal signaling domain, which is crucial for binding to its primary receptor, Patched-1 (PTCH1). Upon binding, PTCH1 releases its inhibition on Smoothened (SMO), activating downstream transcription factors.

For further details on Hedgehog signaling pathways, explore The Cancer Genome Atlas (TCGA) (cancergenome.nih.gov) and Genomic Data Commons (GDC) (gdc.cancer.gov).

Biological Functions of Shh

1. Embryonic Development and Morphogenesis

Shh plays a fundamental role in limb patterning, neural tube formation, and organogenesis. It is particularly crucial for the development of the spinal cord, brain, and skeletal system.

To learn more about Shh’s role in development, visit National Institute of Child Health and Human Development (NICHD) (nichd.nih.gov) and Harvard Stem Cell Institute (hsci.harvard.edu).

2. Neurogenesis and Brain Function

Shh signaling is involved in maintaining neural stem cells, guiding axon growth, and promoting neuroprotection. It has been studied for its role in neurodegenerative disorders such as Parkinson’s disease and Alzheimer’s disease.

For neurogenesis research, refer to National Institute of Neurological Disorders and Stroke (NINDS) (ninds.nih.gov) and Johns Hopkins Brain Science Institute (hopkinsmedicine.org).

3. Cancer Progression and Tumorigenesis

Aberrant Hedgehog signaling activation has been linked to multiple cancers, including medulloblastoma, basal cell carcinoma, and pancreatic cancer. Inhibitors targeting Shh pathway components (such as SMO inhibitors like Vismodegib and Sonidegib) have been developed as therapeutic agents.

For more details on Shh-related cancers, check National Cancer Institute (NCI) (cancer.gov) and MD Anderson Cancer Center (mdanderson.org).

Applications of Recombinant Mouse Shh Protein

1. Stem Cell Research and Regenerative Medicine

Recombinant Shh protein is commonly used to induce stem cell differentiation into neuronal, cardiac, and skeletal lineages. It plays a pivotal role in promoting tissue regeneration and repair.

For resources on stem cell applications, visit Stanford University Stem Cell Institute (med.stanford.edu) and California Institute for Regenerative Medicine (CIRM) (cirm.ca.gov).

2. Drug Development and Therapeutic Targeting

Shh inhibitors and activators are widely explored for treating cancer, neurodegenerative diseases, and tissue injuries. The development of Hedgehog pathway inhibitors has opened new avenues in oncology and regenerative medicine.

For clinical trials involving Hedgehog pathway therapies, refer to ClinicalTrials.gov (clinicaltrials.gov) and U.S. Food and Drug Administration (FDA) (fda.gov).

3. Neural Injury and Spinal Cord Repair

Studies indicate that Shh signaling enhances axonal regrowth and remyelination after spinal cord injury. This makes Shh a potential target for neuroprotective therapies.

For updates on spinal cord injury research, visit Christopher & Dana Reeve Foundation (christopherreeve.org) and National Institute of Neurological Disorders and Stroke (NINDS) (ninds.nih.gov).

Challenges and Future Directions

While recombinant Shh protein offers promising applications, several challenges remain:

  • Dosage and toxicity concerns in clinical applications.
  • Cross-talk with other signaling pathways that complicates therapeutic targeting.
  • Delivery mechanisms for effective in vivo applications.

For ongoing research, explore Massachusetts Institute of Technology (MIT) Biological Engineering (be.mit.edu) and National Human Genome Research Institute (NHGRI) (genome.gov).

Conclusion

Recombinant Mouse Sonic Hedgehog protein (Shh), Partial (Active) remains an essential tool for studying developmental biology, cancer, and regenerative medicine. Ongoing research and therapeutic advancements will further refine its applications.

For further reading, explore Mayo Clinic Research (mayoclinic.org) and Salk Institute for Biological Studies (salk.edu).

As new discoveries emerge, the Shh pathway will continue to be a key target in medical and scientific research, shaping the future of therapeutic interventions.

 

MDA-MB-157 Cells: A Key Model for Triple-Negative Breast Cancer Research and Therapeutic Innovations

by

Introduction to MDA-MB-157 Cells

MDA-MB-157 is a human breast cancer cell line that originates from a triple-negative breast cancer (TNBC) patient. These cells are widely used in cancer research, particularly in studies focused on tumor progression, metastasis, drug resistance, and therapeutic targets. Unlike hormone receptor-positive breast cancer cells, MDA-MB-157 lacks estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, making it a challenging yet significant model for studying aggressive breast cancers.

For more details on triple-negative breast cancer (TNBC), visit the National Cancer Institute (NCI) (cancer.gov) and Centers for Disease Control and Prevention (CDC) (cdc.gov).

Origin and Characteristics

MDA-MB-157 cells were originally isolated from a 43-year-old female patient with breast adenocarcinoma. These cells exhibit high metastatic potential, mesenchymal-like morphology, and significant resistance to conventional therapies. Their aggressive behavior is relevant to studies on epithelial-mesenchymal transition (EMT), invasion, and tumor microenvironment interactions.

For more information on the molecular characterization of MDA-MB-157, refer to the National Center for Biotechnology Information (NCBI) (ncbi.nlm.nih.gov).

Applications in Cancer Research

1. Tumor Progression and Metastasis

MDA-MB-157 cells provide a valuable in vitro model for studying breast cancer invasion and metastasis. Their mesenchymal-like phenotype makes them useful for analyzing migration, extracellular matrix degradation, and cancer stem cell (CSC) properties.

Research papers on breast cancer metastasis can be accessed via PubMed (pubmed.ncbi.nlm.nih.gov) and National Institutes of Health (NIH) (nih.gov).

2. Drug Resistance Studies

Triple-negative breast cancer is notorious for its lack of targeted therapies and high resistance to chemotherapy. Studies using MDA-MB-157 focus on multidrug resistance (MDR) mechanisms, apoptosis evasion, and novel therapeutic agents.

For research on drug resistance in TNBC, visit ClinicalTrials.gov (clinicaltrials.gov) and the U.S. Food and Drug Administration (FDA) (fda.gov).

3. Immunotherapy and Targeted Therapies

Since MDA-MB-157 lacks hormone receptors, researchers explore immune checkpoint inhibitors, monoclonal antibodies, and small molecule inhibitors as potential treatment strategies.

For updates on cancer immunotherapy trials, refer to National Cancer Institute (NCI) (cancer.gov) and Cancer Research UK (cancerresearchuk.org).

4. Gene Expression and Molecular Profiling

MDA-MB-157 cells are commonly analyzed for gene expression profiling and transcriptomic studies to identify oncogenic pathways and novel biomarkers.

For access to publicly available gene expression data, visit Genomic Data Commons (GDC) (gdc.cancer.gov) and The Cancer Genome Atlas (TCGA) (cancergenome.nih.gov).

5. 3D Culture Models and Organoids

Recent advances in three-dimensional (3D) culture techniques and tumor organoid models have significantly improved cancer research. MDA-MB-157 cells have been used to develop organoids that better simulate tumor biology, drug response, and microenvironment interactions.

To learn more about 3D culture technologies, visit Harvard Wyss Institute for Biologically Inspired Engineering (wyss.harvard.edu) and National Cancer Institute’s Organoid Research (cancer.gov).

Challenges and Limitations

Despite its relevance in breast cancer research, the MDA-MB-157 cell line has certain limitations:

  • High heterogeneity: Exhibits genetic instability, making reproducibility difficult.
  • Low tumorigenicity in vivo: Unlike some other TNBC cell lines, MDA-MB-157 has relatively low tumor formation capacity in xenograft models.
  • Limited therapeutic response: Poor sensitivity to standard chemotherapeutics limits its application in drug screening assays.

For a detailed review on breast cancer cell line models, explore research published by American Association for Cancer Research (AACR) (aacr.org) and National Comprehensive Cancer Network (NCCN) (nccn.org).

Future Directions

Ongoing research is aimed at improving the relevance of MDA-MB-157 for personalized medicine by integrating:

  • Organoid and 3D culture models for better mimicking tumor environments.
  • CRISPR-Cas9 gene editing to identify novel druggable targets.
  • Combination therapies to overcome chemoresistance.
  • Single-cell RNA sequencing for deeper molecular profiling.

For insights into emerging breast cancer treatments, visit Stanford Medicine Cancer Center (med.stanford.edu) and Harvard Medical School Cancer Research (hms.harvard.edu).

Conclusion

The MDA-MB-157 cell line remains a valuable tool for understanding triple-negative breast cancer, drug resistance mechanisms, and novel therapeutic approaches. Despite its limitations, it continues to play a pivotal role in preclinical cancer research.

For further reading, check resources from Mayo Clinic Cancer Center (mayoclinic.org) and Memorial Sloan Kettering Cancer Center (mskcc.org).

As research progresses, novel strategies for targeting triple-negative breast cancer using MDA-MB-157 will continue to emerge, offering hope for improved treatments and patient outcomes.

 

Human Bone Marrow Mononuclear Cells (BMMCs) (Frozen, 50 x 10^6): Applications, Isolation, and Research Advances

by

Introduction to Human Bone Marrow Mononuclear Cells (BMMCs)

Human Bone Marrow Mononuclear Cells (BMMCs) are a heterogeneous population of immune and progenitor cells derived from bone marrow. These cells include hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), lymphocytes, monocytes, and other immune cell subtypes. BMMCs play a crucial role in regenerative medicine, immunotherapy, and hematopoietic research.

Researchers and clinicians widely use frozen BMMCs (50 x 10^6 cells per vial) due to their viability, stability, and ease of transport for laboratory and clinical applications. These cryopreserved cells retain their biological functions upon thawing, making them valuable for numerous investigations.

For more information on BMMCs and their clinical applications, refer to the National Center for Biotechnology Information (NCBI) (ncbi.nlm.nih.gov) and the National Institutes of Health (NIH) (nih.gov).

BMMCs Isolation and Cryopreservation

The isolation of BMMCs involves density gradient centrifugation using reagents such as Ficoll-Paque. This technique separates mononuclear cells from erythrocytes and granulocytes based on their density. Protocols for BMMC isolation can be found on Centers for Disease Control and Prevention (CDC) (cdc.gov) and U.S. Food and Drug Administration (FDA) (fda.gov).

Cryopreservation of BMMCs is achieved using dimethyl sulfoxide (DMSO) and fetal bovine serum (FBS) as cryoprotectants. Guidelines for cryopreservation are available from National Cancer Institute (NCI) (cancer.gov) and Stem Cell Research Centers at Harvard University (hscrb.harvard.edu).

Applications of BMMCs in Research and Medicine

1. Regenerative Medicine and Stem Cell Therapy

BMMCs are widely used in regenerative medicine due to their ability to differentiate into various cell types. Clinical trials using BMMCs for cardiac repair and bone regeneration are documented by ClinicalTrials.gov (clinicaltrials.gov).

BMMCs contribute significantly to research on tissue engineering, where they are used in biomaterial scaffolds to enhance tissue regeneration. The Wake Forest Institute for Regenerative Medicine (wakehealth.edu) provides research insights on this application.

2. Hematopoietic Stem Cell Transplantation (HSCT)

Hematopoietic stem cell transplantation (HSCT) using BMMCs is a life-saving therapy for leukemia, lymphoma, and other hematological diseases. For clinical guidelines, visit National Marrow Donor Program (Be The Match) (bethematch.org).

Studies also show the potential of umbilical cord blood transplantation combined with BMMCs for improved hematopoietic recovery. Research from the Fred Hutchinson Cancer Research Center (fredhutch.org) highlights the effectiveness of BMMCs in combination therapies.

3. Immunotherapy and Cancer Research

BMMCs contain immune cells such as natural killer (NK) cells and T cells, which are instrumental in immunotherapy approaches for cancer treatment. Research on immunotherapy strategies utilizing BMMCs can be found at MD Anderson Cancer Center (mdanderson.org) and National Cancer Institute (NCI) (cancer.gov).

BMMCs are also being investigated for their role in chimeric antigen receptor (CAR) T-cell therapy, which has revolutionized cancer treatment. Research insights are provided by Memorial Sloan Kettering Cancer Center (mskcc.org).

4. Autoimmune Disease Treatment

Studies have demonstrated the role of BMMCs in modulating immune responses, making them a potential therapy for autoimmune disorders such as multiple sclerosis (MS) and rheumatoid arthritis (RA). Clinical research data are available at National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (niams.nih.gov) and Johns Hopkins Autoimmune Disease Research Center (hopkinsmedicine.org).

5. Neurological Disorders and CNS Repair

Recent studies indicate that BMMCs can aid in the repair of central nervous system (CNS) damage caused by stroke, spinal cord injury, and neurodegenerative diseases like Parkinson’s and Alzheimer’s. The National Institute of Neurological Disorders and Stroke (NINDS) (ninds.nih.gov) provides further research on the subject.

Challenges and Future Directions

Despite their vast potential, the use of BMMCs presents challenges, such as donor variability, risk of contamination, and ethical considerations. Regulatory guidelines for the use of human-derived cells are provided by the U.S. Food and Drug Administration (FDA) (fda.gov) and World Health Organization (WHO) (who.int).

Ongoing research focuses on enhancing the differentiation potential of BMMCs and improving cryopreservation techniques to ensure higher post-thaw viability. Scientists at Stanford University Stem Cell Institute (med.stanford.edu) and University of California, San Francisco (UCSF) Stem Cell Program (stemcell.ucsf.edu) are actively exploring these advancements.

Conclusion

Human Bone Marrow Mononuclear Cells (BMMCs) represent a critical component in modern biomedical research and clinical applications. Their use in stem cell therapy, immunotherapy, regenerative medicine, and hematological treatments underscores their importance in advancing medical science.

For further resources, visit the National Heart, Lung, and Blood Institute (NHLBI) (nhlbi.nih.gov) and Mayo Clinic Research (mayoclinic.org). As research continues to progress, BMMCs will likely play an increasingly pivotal role in treating and understanding various diseases.

 

Trypsin Activity Colorimetric Assay Kit: A Comprehensive Overview

by

The Trypsin Activity Colorimetric Assay Kit is an advanced tool used to measure the activity of trypsin, a key digestive enzyme that plays an essential role in protein breakdown. This kit is commonly used in research fields such as biochemistry, pharmacology, and molecular biology to analyze trypsin’s function in various physiological and pathological processes.

Key Features of the Trypsin Activity Colorimetric Assay Kit

  1. High Sensitivity: This assay offers high sensitivity in detecting trypsin activity, allowing for precise quantification in complex biological samples such as plasma, serum, or tissue extracts. Studies using this kit have been published on databases like PubMed.
  2. Quantitative Measurement: By employing a colorimetric detection method, the kit enables accurate quantification of trypsin activity. The change in color intensity is proportional to the enzyme’s activity level, making it an excellent tool for high-throughput screening in drug development, as seen in research funded by the NIH.
  3. Wide Applications: This kit is applicable across various biological studies involving digestive enzymes, such as those focusing on pancreatic function and digestive disorders. It has been used in studies supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Mechanism of Action

Trypsin is a serine protease produced in the pancreas as an inactive zymogen, trypsinogen. Upon activation, trypsin breaks down proteins into smaller peptides, a critical process in the digestive system. By using a colorimetric substrate that reacts with trypsin, the assay kit generates a measurable color change that corresponds to the enzyme’s activity, which is then quantified using a spectrophotometer.

The specificity of the kit ensures accurate measurement, making it a valuable tool for researchers studying protease inhibitors or investigating trypsin’s role in diseases such as acute pancreatitis, as described in research on NIH-funded platforms.

Applications in Research

  1. Pancreatic Disorders: The kit is widely used in the study of acute and chronic pancreatitis, where trypsin levels are elevated. Research projects funded by the NIDDK have utilized this kit to explore how trypsin activity contributes to pancreatic inflammation.
  2. Protease Inhibitor Studies: Trypsin inhibitors are of significant interest in therapeutic development, particularly for conditions like cystic fibrosis and hereditary pancreatitis. The Trypsin Activity Assay Kit is often employed to screen for protease inhibitors in drug discovery efforts, which is a focus of the FDA.
  3. Digestive Enzyme Research: Understanding how trypsin and other digestive enzymes function is crucial in gastrointestinal research. The kit has been used in various studies, such as those conducted by academic institutions supported by the National Science Foundation (NSF), to investigate how enzyme activity is regulated in the digestive system.

Procedure and Workflow

The Trypsin Activity Colorimetric Assay Kit operates on a straightforward workflow:

  1. Sample Preparation: Biological samples such as serum, plasma, or tissue extracts are prepared and placed in a 96-well microplate, which is a common format used in NIH and NSF-supported studies.
  2. Reaction Initiation: A colorimetric substrate, specific to trypsin, is added to each well. Upon cleavage by trypsin, the substrate releases a chromophore, resulting in a visible color change.
  3. Measurement: The reaction is measured using a spectrophotometer at a specific wavelength, typically 405 nm. The intensity of the color is directly proportional to the amount of active trypsin in the sample, a principle utilized in studies archived on PubMed Central.
  4. Data Analysis: Results are analyzed to determine trypsin activity, which can be compared across different experimental conditions or between control and disease samples.

Advantages of the Trypsin Activity Colorimetric Assay Kit

  • High Throughput: The kit’s 96-well plate format allows for the simultaneous analysis of multiple samples, ideal for large-scale research or drug screening programs in laboratories supported by NIH funding.
  • Versatility: Suitable for measuring trypsin activity in a variety of sample types, including serum, plasma, and cell lysates. This makes it useful for studies investigating multiple biological systems, as demonstrated by research on PubMed.
  • Cost-Effective: Compared to more advanced techniques like mass spectrometry, this kit provides a simpler, cost-effective solution for measuring enzyme activity, making it a popular choice in academic research supported by the NSF.

Applications in Education and Government Research

The Trypsin Activity Colorimetric Assay Kit is not only a tool for research but also a valuable educational resource. Students in biochemistry and molecular biology courses use it to learn fundamental techniques in enzyme kinetics. Government research institutions such as the Centers for Disease Control and Prevention (CDC) and FDA utilize the kit in public health and regulatory studies, where accurate measurement of enzyme activity is critical for understanding disease mechanisms.

Conclusion

The Trypsin Activity Colorimetric Assay Kit is indispensable in enzyme research, offering precise and high-throughput measurement of trypsin activity in a variety of sample types. Its application spans studies on pancreatic function, protease inhibitors, and digestive disorders, making it a versatile tool in both basic research and clinical settings. Whether in academic labs or government-funded research projects, this kit plays a critical role in advancing the understanding of digestive enzymes and their impact on health.

Southern Blot

by

Introduction

A Southern blot is a laboratory method used to detect specific DNA molecules among many other DNA molecules. The technique is named after its inventor, Edward Southern. As a laboratory procedure, Southern blots can be used to analyze an organism’s total DNA, also known as its genome, to identify a specific sequence of interest.

The first step in a Southern blot is to prepare the DNA mixture by breaking it into small fragments using a protein called a restriction enzyme. The mixture of DNA fragments is then separated by size using a technique called gel electrophoresis. After separation, the double-stranded DNA pieces denature or separate into single strands within the gel. The DNA is then transferred from the gel to a transfer membrane. Although this step is what gives the technique the name “southern transfer,” the term is generally used to describe the entire procedure.

Once the transfer is complete, the membrane carries all the bands originally on the gel. The membrane is then treated with a small piece of DNA or RNA called a probe, which has been designed to have a sequence that is complementary to a particular DNA sequence in the sample; this allows the probe to hybridize or bind to a specific DNA fragment on the membrane. Also, the probe has a label, which is usually a radioactive atom or a fluorescent dye. Thus, after hybridization, the probe allows the DNA fragment of interest to be detected among the many different DNA fragments on the membrane.

General procedure for drying

1. Sample homogenization involving DNA/RNA/protein purification that is performed after extraction from a variety of sources, such as cells or tissues.

2. Digest DNA with restriction enzymes into fragments, which is not necessary for RNA (northern blot).

3. Separation of the molecule of interest by membrane electrophoresis, generally on agarose gel for DNA fragments. In the case of RNA samples, they can be separated on an agarose gel in the presence of formaldehyde as a denaturing agent. This is necessary since formaldehyde limits the secondary structures of RNA molecules.

4. Transfer the molecules (DNA/RNA fragments) to a nitrocellulose membrane/nylon membrane from the gel.

5. Prehybridization (Blocking): Washing the nylon membrane with a prehybridization or blocking solution comprising salmon sperm DNA is required to block non-specific DNA interactions and also helps reduce background noise. Alternatively, there are some commercially available blocking buffers, such as PerfectHyb™ Plus buffer, in which salmon sperm DNA is not required for blocking purposes.

6. For probe preparation, a fresh 32P alpha-labelled dCTP-labeled DNA probe is prepared.

7. Hybridization or identification of the molecule that is achieved by incubating the blot with the specific labelled probe.

8. For detection of the probe and the DNA/RNA sequence of interest, the film is exposed to -80°C.

Beginning

Restriction endonucleases, which is enzymes, are used to break DNA into small fragments. These fragments are then separated by electrophoresis. The fragments obtained are then classified according to their size (kDa). Thus, the DNA fragments are transferred to blotting paper where they are incubated with probes. The probes used in Southern blotting can be very selective. They can selectively bind with a resolution of 1 in a million and the characteristics to bind to the intended target fragments.

Necessary materials reagents

  • The buffer used for electrophoresis is TAE or TBE.
  • The preferred agarose should be electrophoresis grade.
  • For DNA staining, ethidium bromide (0.5 µg ml–1, dissolved in H2O) is used. But there are other DNA staining dyes, such as SYBR green, that can replace ethidium bromide for safe handling.
  • 2X and 20X SSC (20X SSC composition includes 3.0 M NaCl and 0.3 M sodium citrate)
  • 6X DNA Loading Buffer consisting of 0.25% Bromophenol Blue, 0.25% Xylene Cyanol FF, and 30% Glycerol in water.
  • Suitable DNA markers of variable molecular weight, also called DNA ladders, are used as reference standards.
  • The prehybridization and hybridization mixture consists of 0.5% SDS, 6X SSC, 5X Denhardt’s solution, and 100 mg ml–1 sheared denatured salmon sperm DNA of yeast tRNA.
  • The widely used Denhardt solution for hybridization is composed of 0.02% Ficoll, 0.02% polyvinylpyrrolidone, and 0.02% bovine serum albumin (BSA)
  • Paraffin oil
  • Cellulose nitrate or nitrocellulose membrane filter with uniform porosity. (eg, Millipore 25 HAWP; nylon membranes used for blot protocols are available under various trade names from commercial vendors)
  • RNase A (20 pg ml–1 in 2X SSC) is required for specific cleavage.
  • Restriction enzyme and an appropriate buffer are used.
  • Radioactively labelled RNA as a probe for specific detection where autoradiography is performed.
  • For the detection of RNA labelled with labels such as 3H, 35S, 125I or 14C, 2,5-diphenyloxazole (PPO) in toluene at a concentration of 20% w/vol is required.

Team

1. Transfer of narrow strips of gel can be achieved using three pieces of glass or Plexiglas that are 5 cm × 20 cm in size with a thickness similar to the thickness of the gel.

2. There is a requirement for coarse, dry filter paper (four to five in number) or paper towels 10 cm × 18 cm in size.

3. The hybridization dish has a larger dimension (0.8 mm depth × 2 cm height × ~1 cm length) than the membrane used for hybridization, and the material used to develop the hybridization dish is Perspex (note: several alternative procedures for hybridization follow)

4. Four narrow pieces of Perspex that are similar in thickness to gel. Perspex length is sufficient to surround the gel at a distance of ~3 mm

5. A tray 20–50 mm (approx.) deep and 20 mm (approx.) in length and width larger than the gel

6. A sheet of glass long enough to fit in the pan and narrower to have a 10mm gap on each side

7. Several thick pieces of filter paper have a large area compared to the gel. The length of the filter paper is suitable to cover the glass sheet and can be immersed inside the tray.

8. A moistened piece of nitrocellulose membrane, which has a wider area that can cover the entire gel. The nitrocellulose membrane is placed on top of four strips of Perspex. Wetting of the nitrocellulose membrane is done using 2X SSC.

9. Paper towels that are stacked on top of each other.

10. Apparatus for straining gel.

11. A gel tank is necessary to perform electrophoresis.

12. Power supply is required for all device configurations.

Reagent Configuration

  • DNA: The entire procedure begins using DNA digested with enzymes of varying concentrations that will quantify the optimal concentration of DNA and specify the restriction enzyme to be used. Generally, an amount of 1 µg of DNA derived from clones (eg, from plasmid or bacteriophage clones) is sufficient for plasmids having low copy numbers. We need larger amounts to carry out the separation of complex DNA (eg genomic DNA). The advisable range to consider would be 5 to 10 µg.
  • The electrophoresis buffer used is TAE, which has a composition of 40 mM Tris, 20 mM acetic acid, 1 mM EDTA with a pH range of 7.4 to 8.2, which is normally prepared as a stock concentration of 20X or TBE composed of 89 mM Tris, 2.5 mM EDTA, 89 mM borate, normally made as a 10× stock)
  • TAE is recommended to be better when running gels for a shorter time interval and when recovery of DNA fragments from the gel is to be carried out.
  • TBE is considered to be a better buffer, especially when we have to run the gels for longer than 2 h.

Request

Southern blot is used in various applications. The main use of the Southern blot is to identify a specific DNA in a DNA sample. It is mainly used in the identification of viral infections and certain bacterial infections. In rDNA technology, the Southern blot technique is used to isolate a particular DNA. It is also useful in the study of genetic mutations and rearrangements, this property is used to diagnose neonatal diseases and genetic diseases. Due to the accuracy in DNA identification, this technique is used in phylogenetic studies, paternity and maternity analysis, forensic studies and personal identification.

Southern blotting can be applied to study the structure of a gene or to elucidate restriction enzyme maps. In particular, Southern blotting can be used to identify the methylated sites present for particular genes. This can be implemented by applying restriction nucleases such as MspI and HpaII, which can identify and cleave between identical sequences. The discovery of RFLPs by Southern blotting has aided in the mapping of several genomes that were crucial to map. In the field of immunology, clonal rearrangements of immunoglobulins, as well as T-cell receptor genes that play an important role in eliciting an immune response, can be analyzed by Southern blotting.

Slipped-strand mispairing

by

Abstract

Simple repetitive DNA sequences are a widespread and abundant feature of genomic DNA. The following features characterize such sequences: (1) they typically consist of a variety of 1-10 base repeat motifs, but may also include much larger repeats; (2) larger repeating units often include shorter ones within them; (3) long polypyrimidine and poly-CA tracts are often found; and (4) tandem arrangements of closely related motifs are often found. We propose that slipped strand mismatch events, together with unequal crossing over, can easily explain all of these features.

The frequent occurrence of long tandem repeats of particular motifs (polypyrimidine and poly-CA tracts) appears to be the result of non-random patterns of nucleotide substitution. We argue that the intrahelical process of slipped strand mismatching is much more likely to be the major factor in the initial expansion of short repeat motifs and that, after the initial expansion, simple tandem repeats may be predisposed to further expansion by unequal crossover or other interhelical events due to their propensity for mismatching.

Evidence is presented that single base repeats (the shortest possible motifs) are represented by longer series in mammalian introns than would be expected randomly, supporting the idea that SSM may be a ubiquitous force in the evolution of the eukaryotic genome. Thus, simple repetitive sequences may represent a natural ground state of DNA not selected for coding functions.

Key points

  • Altered gene expression is the result of SSM and, depending on where the increase or decrease in short repeat sequences occurs relative to the promoter, will be regulated at the level of transcription or translation. The result is an ON or OFF phase of a gene or genes.
  • SSM can result in an increase or decrease in the number of short repeat sequences. Short repeat sequences are from 1 to 7 nucleotides and can be homogeneous or heterogeneous repetitive DNA sequences.
  • Transcriptional regulation can occur if the repeats are located in the promoter region at the RNA polymerase binding site, -10 and -35 upstream of the gene(s).
  • SSM induces transcriptional regulation by changing short repeat sequences located outside the promoter. If there is a change in the short repeat sequence, it can affect the binding of a regulatory protein, such as an activator or a repressor.

Key terms

Slipped strand mismatch: a process that produces a mismatch of short repeat sequences between the parent strand and the daughter strand during DNA synthesis.

7.1D: Slipped-Strand Mispairing - Biology LibreTexts

Slipped strand mismatch (SSM) is a process that results in the mispairing of short repeated sequences between the mother and daughter strand during DNA synthesis. This RecA-independent mechanism can occur during DNA replication or DNA repair and can be on the leading or lagging strand and can result in an increase or decrease in the number of short repeat sequences. Short repeat sequences are from 1 to 7 nucleotides and can be homogeneous or heterogeneous repetitive DNA sequences.

Altered gene expression is the result of SSM and, depending on where the increase or decrease in short repeat sequences occurs relative to the promoter, will be regulated at the level of transcription or translation. The result is an ON or OFF phase of a gene or genes. Transcriptional regulation occurs in several ways. One possibility is if the repeats are located in the promoter region at the RNA polymerase binding site, -10 and -35, upstream of the gene(s). The opportunistic pathogen H. influenza has two divergently oriented promoters in the gene shift and hifB fimbriae.

Overlapping promoter regions have TA dinucleotide repeats at -10 and -35 sequences. Via SSM, the TA repeat region can undergo the addition or subtraction of TA dinucleotides, resulting in the reversible ON or OFF phase of hifA and hifB transcription. The second way that SSM induces transcriptional regulation is by changing short repeat sequences located outside of the promoter. If there is a change in the short repeat sequence, it can affect the binding of a regulatory protein, such as an activator or a repressor. It can also give rise to differences in the post-transcriptional stability of the mRNA.

Restriction Fragment Length Polymorphisms (RFLPs)

by

Abstract

Restriction fragment length polymorphisms, or RFLPs, are differences between individuals in the lengths of DNA fragments cut by enzymes. Restriction enzymes are proteins that cut DNA at short, specific sequences called restriction sites. After cutting a segment of DNA with restriction enzymes, researchers can examine the fragments using a laboratory method called gel electrophoresis, which separates DNA fragments based on their size.

If two individuals have differences in their DNA sequences at particular restriction sites, the restriction enzymes will cut their DNA into fragments of different lengths. There may also be differences in the number of DNA fragments observed between two or more individuals. Gentaur RFLP analysis can be used as a form of genetic testing to see if an individual carries a mutant gene for a disease that runs in their family.

Beginning

Restriction endonucleases are enzymes that cut long DNA into short pieces. Each restriction endonuclease targets different nucleotide sequences in a DNA strand and therefore cuts at different sites. The distance between the cleavage sites of a given restriction endonuclease differs between individuals. Therefore, the length of the DNA fragments produced by a restriction endonuclease will differ between individual organisms and species.

How does it work?

The RFLP is carried out through a series of steps that are briefly described below:

  • Extraction of DNA

To begin with, DNA is extracted from blood, saliva, or other samples and purified.

  • DNA fragmentation

The purified DNA is digested using restriction endonucleases. The recognition sites of these enzymes are generally 4 to 6 base pairs in length. The shorter the recognized sequence, the greater the number of fragments generated from digestion.

For example, if there is a short GAGC sequence that occurs repeatedly in a DNA sample. The restriction endonuclease that recognizes the GAGC sequence cuts the DNA at each repeat of the GAGC pattern. If one sample repeats the GAGC sequence 4 times while another sample repeats it 2 times, the length of the fragments generated by the enzyme for the two samples will be different.

  • Gel electrophoresis

Restriction fragments produced during DNA fragmentation are analyzed by gel electrophoresis. The fragments are negatively charged and can be easily separated by electrophoresis, which separates molecules based on their size and charge. The fragmented DNA samples are placed in the chamber containing the electrophoretic gel and two electrodes. When an electric field is applied, the fragments migrate towards the positive electrode. Smaller fragments move faster through the gel, leaving larger ones behind, and therefore the DNA samples separate into distinct bands on the gel.

  • Band Visualization

The gel is treated with luminescent dyes to make the DNA bands visible.

RFLP Applications

RFLP has been used for various genetic analysis applications since its invention.

Some of these key RFLP applications are listed below:

  • Determine the status of genetic diseases such as Cystic Fibrosis in an individual.
  • To determine or confirm the origin of a DNA sample, such as in paternity tests or criminal investigations.
  • In genetic mapping to determine recombination rates showing the genetic distance between loci.
  • To identify a carrier of a disease-causing mutation in a family.

RFLP Disadvantages

1. Since its invention, RFLP has been a widely used genome analysis technique in forensic science, medicine, and genetic studies. However, it has become almost obsolete with the advent of relatively simple and less expensive DNA profiling technologies, such as polymerase chain reaction (PCR).

2. The RFLP procedure requires numerous steps and takes weeks to obtain results, while techniques such as PCR can amplify target DNA sequences in a few hours.

3. In addition, RFLP requires a large DNA sample, the isolation of which can be a laborious and time-consuming process. In contrast, PCR can amplify minute amounts of DNA in a matter of hours.

4. Due to numerous reasons like these, the PCR technique has largely replaced RFLP in most applications that require DNA sequencings, such as paternity testing or forensic sample analysis.

5. Furthermore, the identification of single nucleotide polymorphisms in the Human Genome Project has nearly replaced the need for RFLP in disease state analysis.